Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Treasury Shares (2016 - 2023)

Historic Treasury Shares for Viking Therapeutics (VKTX) over the last 10 years, with Q4 2023 value amounting to $2.9 million.

  • Viking Therapeutics' Treasury Shares rose 5283.0% to $2.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.9 million, marking a year-over-year increase of 5283.0%. This contributed to the annual value of $2.2 million for FY2023, which is 1737.92% up from last year.
  • As of Q4 2023, Viking Therapeutics' Treasury Shares stood at $6.8 million, which was down 0.0% from $6.8 million recorded in Q3 2023.
  • Over the past 5 years, Viking Therapeutics' Treasury Shares peaked at $2.9 million during Q4 2023, and registered a low of $352726.0 during Q4 2019.
  • In the last 5 years, Viking Therapeutics' Treasury Shares had a median value of $1.0 million in 2021 and averaged $1.3 million.
  • The largest annual percentage gain for Viking Therapeutics' Treasury Shares in the last 5 years was 3268.89% (2023), contrasted with its biggest fall of 0.0% (2023).
  • Over the past 2 years, Viking Therapeutics' Treasury Shares (Quarter) stood at $6.8 million in 2022, then changed by 0.0% to $6.8 million in 2023.
  • Its Treasury Shares stands at $2.9 million for Q4 2023, versus $2.2 million for Q3 2023 and $2.2 million for Q2 2023.